(Q40063948)

17 September 2017

title

Alkoxymethylenephosphonate analogues of (Lyso) phosphatidic acid stimulate signaling networks coupled to the LPA2 receptor (English)

1 reference

17 September 2017

8

Gordon B Mills

1 reference

17 September 2017

Joanna Gajewiak

1

1 reference

17 September 2017

Ryoko Tsukahara

2

1 reference

17 September 2017

Tamotsu Tsukahara

3

1 reference

17 September 2017

Yuko Fujiwara

4

1 reference

17 September 2017

Shuanxing Yu

5

1 reference

17 September 2017

Yiling Lu

6

1 reference

17 September 2017

Mandi Murph

7

1 reference

17 September 2017

Gabor Tigyi

9

1 reference

17 September 2017

Glenn D Prestwich

10

1 reference

17 September 2017

language of work or name

1 reference

1 December 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

2

1 reference

17 September 2017

issue

12

1 reference

17 September 2017

page(s)

1789-1798

1 reference

Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action. Evidence against a second messenger role for lysophosphatidic acid

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

Biological functions of a novel lipid mediator, cyclic phosphatidic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

Nanoparticle networks reduce the flammability of polymer nanocomposites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

The emerging role of lysophosphatidic acid in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Increased production of bioactive lysophosphatidic acid by serum lysophospholipase D in human pregnancy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Abnormal serum lysophospholipids in multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Bioactive lysophospholipids and their G protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg Family

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Are the curves in all the right places?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Selective ligands for lysophosphatidic acid receptor subtypes: gaining control over the endothelial differentiation gene family.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Activity of 2-substituted lysophosphatidic acid (LPA) analogs at LPA receptors: discovery of a LPA1/LPA3 receptor antagonist.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Molecular mechanisms of lysophosphatidic acid action

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Malonate crown ethers as building blocks for novel D-pi-A chromophores

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Enantioselective responses to a phosphorothioate analogue of lysophosphatidic acid with LPA3 receptor-selective agonist activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Phosphorothioate analogues of alkyl lysophosphatidic acid as LPA3 receptor-selective agonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Alpha-substituted phosphonate analogues of lysophosphatidic acid (LPA) selectively inhibit production and action of LPA

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

5'-O-phosphonomethyl-2',3'-dideoxynucleosides: synthesis and anti-HIV activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Synthesis and molecular recognition of phosphatidylinositol-3-methylenephosphate.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Nanowindow-regulated specific capacitance of supercapacitor electrodes of single-wall carbon nanohorns

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Synthesis and biological activity of PTEN-resistant analogues of phosphatidylinositol 3,4,5-trisphosphate

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Synthesis, structure-activity relationships, and the effect of polyethylene glycol on inhibitors of phosphatidylinositol-specific phospholipase C from Bacillus cereus

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Fatty alcohol phosphates are subtype-selective agonists and antagonists of lysophosphatidic acid receptors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Differential expression of lysophosphatidic acid receptor-2 in intestinal and diffuse type gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

LPA2 receptor mediates mitogenic signals in human colon cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Src promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

A module of negative feedback regulators defines growth factor signaling

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200700111

7 January 2021

Identifiers

DOI

10.1002/CMDC.200700111

1 reference

17 September 2017

1 reference